[Curative treatment of Duhring-Brocq disease by BCG vaccination. 2-to-6-year post-therapeutic retrospective study].
D000328:Adult; D000368:Aged; D001500:BCG Vaccine / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003874:Dermatitis Herpetiformis / Q000150:complications / Q000188:drug therapy* / Q000534:rehabilitation; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed; D008297:Male; D008722:Methods; D008875:Middle Aged; D012189:Retrospective Studies; D014374:Tuberculin Test; D014397:Tuberculosis, Pulmonary / Q000150:complications
D001500:BCG Vaccine
Traitement curatif de la maladie de Duhring-Brocq par le vaccin B.C.G. Recul post-thérapeutique de deux à six ans